Back to User profile » Dr Ming-Szu Hung

Papers published by Dr Ming-Szu Hung:

Original Research

Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides difficile Infection Among Patients with Lung Cancer

Chung YS, Lin YC, Hung MS, Ho MC, Fang YH

OncoTargets and Therapy 2022, 15:1563-1571

Published Date: 28 December 2022

Original Research

Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer

Ho MC, Chung YS, Lin YC, Hung MS, Fang YH

OncoTargets and Therapy 2022, 15:1573-1582

Published Date: 28 December 2022

Original Research

Low Concentrations of Dehydroepiandrosterone Sulfate are Associated with Depression and Fatigue in Patients with Non-Small-Cell Lung Cancer After Chemotherapy

Fang YH, Hsieh MJ, Hung MS, Lin YC, Kuo LT, Lu ML, Tzang BS, Chen VCH

Neuropsychiatric Disease and Treatment 2020, 16:2103-2109

Published Date: 17 September 2020

Original Research

Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study

Fang YH, Yang YH, Hsieh MJ, Hung MS, Lin YC

Cancer Management and Research 2019, 11:8539-8546

Published Date: 19 September 2019

Original Research

Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer

Fang YH, Hsu CC, Hsieh MJ, Hung MS, Tsai YH, Lin YC

OncoTargets and Therapy 2017, 10:5173-5177

Published Date: 25 October 2017